http://www.neurology.org/cgi/content/abstract/57/10/1891
Neurology 2001;57:1891-1893
L. M.E. Grimaldi, MD, G. Salemi,
MD, G. Grimaldi, MD, A. Rizzo, MD, R. Marziolo, MD, C. Lo Presti, MD, D.
Maimone, MD and G. Savettieri, MD
From the Department of Neuroscience
(Dr. L. Grimaldi), Azienda Unita Sanitaria Locale 2, Caltanissetta; Institute
of Neuropsychiatry (Drs. Salemi and Savettieri), University of Palermo;
Neurology Unit (Drs. G. Grimaldi and Rizzo), Umberto I Hospital, Enna;
Neurology Unit (Dr. Marziolo), Sant’Elia Hospital, Caltanissetta; Sicilian
Rehabilitation Consortium (Dr. Lo Presti), Enna; and Neurology Unit (Dr.
Maimone), Garibaldi Hospital, Catania, Italy.
Brief Communications
Twenty years after a first survey,
a follow-up study was performed on the prevalence of MS in Enna (Sicily),
southern Italy.
The prevalence of definite MS rose
from 53 to 120.2 per 100,000 population.
The incidence of definite MS for
the period 1986 to 1995 was 5.7 per 100,000 per year.
The innermost part of Sicily shows
an elevated prevalence of MS, second only to Sardinia in the Mediterranean
area.
© 2001 American Academy of Neurology